Bath & Body Works (BBWI) EBITDA Margin (2009 - 2026)

Bath & Body Works (BBWI) has reported EBITDA Margin for 18 consecutive years, with 14.27% the latest figure, recorded in Q3 2026.

• On a quarterly basis, EBITDA Margin rose 413.0% year-over-year to 14.27% in Q3 2026; TTM through Aug 2026 was 15.35%, a 177.0% decrease from a year earlier, with the FY2026 full-year figure at 15.44%, down 188.0% from the prior year.
• EBITDA Margin was 14.27% for Q3 2026 at Bath & Body Works, down from 21.99% in the prior quarter.
• Over five years, EBITDA Margin peaked at 29.04% in Q1 2022 and troughed at 10.1% in Q4 2025.
• A 5-year average of 16.45% and a median of 14.21% in 2023 frame the typical range for EBITDA Margin.
• Across the five-year window, EBITDA Margin tumbled 1174 bps in 2022 and surged 413 bps in 2026, its largest moves.
• Over 5 years, EBITDA Margin stood at 12.59% in 2022, then grew by 12 bps to 14.15% in 2023, then fell by 4 bps to 13.54% in 2024, then decreased by 25 bps to 10.1% in 2025, then jumped by 41 bps to 14.27% in 2026.
• The last three EBITDA Margin figures came in at 14.27% (Q3 2026), 21.99% (Q1 2026), and 10.1% (Q4 2025), per Business Quant data.